Bio-Techne
S&P 500
$72.12
+0.06%
Delayed · cached 15 min
Fair value analysis
TECH
Bio-Techne
$72.12
Close used for this calculation
$24.26Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
32/100
Quality radar
Consensus fair value
$24.26
Above FV▼ -66.4% against the close used
Model range $5.61 – $27.67
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$5.61Fair value$24.26Bull$27.67
FairClose
52-week traded range
52W low $43.3052W high $72.48
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Bio-Techne closed at $72.12, 197.3% above the consensus fair value of $24.26 drawn from 8 valuation models.
Financial DNA score 32/100 — Weak. P/E of 62.2x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$26.24
-63.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=4.8%, r=10%, tg=3%, n=10yr
Graham Number
$18.72
-74.0%
√(22.5 × EPS × BVPS)
EPS=1.16, BVPS=13.43 · outside Graham range (P/E 62.2, P/B 5.4) — asset-light, treat as a rough floor
P/E Fair Value
$23.20
-67.8%
EPS × 20x (sector P/E)
EPS=1.16, Sector P/E=20x
Peter Lynch (PEG)
$5.61
-92.2%
EPS × Growth% (PEG = 1 is fair)
EPS=1.16, g=4.8%
EV/EBITDA
$27.67
-61.6%
(EBITDA × 12.4x − Net Debt) ÷ Shares
EBITDA=349.25M
Book Value (P/B)
$9.86
-86.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=13.43, ROE=8.6%, g=4.8%, r=10%
Reverse DCF
$72.12
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 22.5% | Historical: 4.8%
Margin of Safety
$17.04
-76.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=22.72, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.